News

Five questions to test your knowledge of the prevalence, risk, and classification of RA.

The approval is based on data from two randomized, sham injection-controlled, double-masked phase 3 clinical trials with patient follow-up for 3 years.

Be vigilant for diffuse idiopathic skeletal hyperostosis in patients who have ankylosing spondylitis, since they may be less clearly symptomatic.

Concerns have been raised in the past about the possibility of infection caused by immune suppression.

Data from 2 phase 3 studies of secukinumab (Cosentyx) in patients with psoriatic arthritis and ankylosing spondylitis will be presented at an upcoming meeting.

Here: highlights of some of the studies that will be presented at the American College of Rheumatology 2018 Annual Meeting in Chicago from October 19 to 24.

A potential pathway for treatment and a way to assess the prognosis of patients with rheumatoid arthritis.

Since current treat-to-target practice relies on disease activity measured at a single point in time, electronic patient-reported outcome measures (e-PROMs) represent a potentially powerful tool for monitoring patient disease activity between office visits.

Take the quiz to see how much you know about SLE-related complications during pregnancy.

Canadian researchers have identified predictors of subclinical cardiomyopathy in patients with lupus.

Cognitive behavioral therapy for insomnia may slow or even reverse the atrophy of cortical gray matter associated with fibromyalgia.

Patients with rheumatic diseases should limit their participation in physical activity. True or false?

The approval is based on data from the JIGSAW-118 study, which was designed to determine the appropriate dosing regimen of Actemra SC in children with SJIA.

Moderate physical activity improved function and quality of life but failed to have the expected impact on pain.

Test your knowledge of RA comorbidities with this short quiz.

A subcutaneous formulation of tocilizumab (Actemra) is now approved for the treatment of active systemic juvenile idiopathic arthritis in patients at least 2 years old.

Patients with obstructive sleep apnea are at increased risk for gout, even beyond the first year after the sleep disorder is diagnosed.

At 12 weeks, patients with rheumatoid arthritis receiving filgotinib responded and achieved low disease activity at significantly higher rates compared to placebo.

Findings from the first report on sex-specific predictors of spinal radiographic progression in ankylosing spondylitis.

What are the implications for the timing of these procedures in younger patients with AS?

Authors of a new study devised a new algorithm that can help physicians identify and manage diabetic patients at increased fracture risk. 

This dietary pattern has already been shown to reduce overall mortality, cardiovascular disease, and cancer. Do the benefits extend to RA?

Swedish researchers found a 30% increase in the risk of fractures-independent of the degree of weight loss.

Identifying populations at risk may provide opportunities for primary prevention.

The designation was based on data from 7 clinical trials over the past decade which assessed Xolair's efficacy and safety versus various food allergens such as peanut, milk, and egg.

Galafold differs from common enzyme replacement therapy in that it increases the activity of the body’s deficient enzyme.

Fish oil supplements proved no better than placebo at relieving dry eye disease.

The oral therapy was previously approved for use in children aged 6 years and older with CF and 2 copies of the F508del-CFTR mutation, the most common genetic form of the disease.

When disease activity is high and/or function impaired, consider depression a likely comorbidity that may be a result of inflammation.

The goal of the study: to identify young patients at risk before any clinical symptoms develop.